Period Ending | Feb 2, 2013 | Oct 27, 2012 | Jul 28, 2012 | Apr 28, 2012 |
---|
Total Revenue
|
18,246,000
|
18,130,000
|
20,570,000
|
17,808,000
| Cost of Revenue | 11,880,000 | 11,863,000 | 13,544,000 | 11,625,000 | |
Gross Profit
|
6,366,000
|
6,267,000
|
7,026,000
|
6,183,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 4,217,000 | 4,139,000 | 4,066,000 | 4,086,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 399,000 | 395,000 | 391,000 | 383,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
1,750,000
|
1,733,000
|
2,569,000
|
1,714,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 6,000 | 5,000 | 4,000 | 72,000 |
|
Earnings Before Interest And Taxes | 1,756,000 | 1,738,000 | 2,573,000 | 1,786,000 |
|
Interest Expense | 166,000 | 155,000 | 155,000 | 156,000 |
|
Income Before Tax | 1,590,000 | 1,583,000 | 2,418,000 | 1,630,000 |
|
Income Tax Expense | 569,000 | 636,000 | 886,000 | 595,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 1,021,000 | 947,000 | 1,532,000 | 1,035,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
1,021,000
|
947,000
|
1,532,000
|
1,035,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
1,021,000
|
947,000
|
1,532,000
|
1,035,000
|
|